Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
IBRXImmunitybio	$2.38bn	n/a	n/a
LBPHLongboard Pharmaceuticals	$2.34bn	n/a	n/a
DICEDice Therapeutics	$2.27bn	n/a	n/a
ARWRArrowhead Pharmaceuticals	$2.22bn	n/a	n/a
DCPHDeciphera Pharmaceuticals	$2.21bn	n/a	n/a
VCYTVeracyte	$2.14bn	61.78	n/a
NAMSNewAmsterdam Pharma NV	$2.08bn	n/a	n/a
DNLIDenali Therapeutics	$2.05bn	n/a	n/a
RXRXRecursion Pharmaceuticals	$2.04bn	n/a	n/a
CGONCG Oncology	$1.98bn	n/a	n/a
BCRXBioCryst Pharmaceuticals	$1.96bn	n/a	n/a
AGIOAgios Pharmaceuticals	$1.94bn	n/a	n/a
BLTEBelite Bio	$1.92bn	n/a	n/a
IRONDisc Medicine	$1.89bn	n/a	n/a
IDYAIdeaya Biosciences	$1.87bn	n/a	n/a
BLUBELLUS Health	CA$2.47bn	n/a	n/a
FUSNFusion Pharmaceuticals	$1.83bn	n/a	n/a
FOLDAmicus Therapeutics	$1.83bn	n/a	n/a
ADPTAdaptive Biotechnologies	$1.79bn	n/a	n/a
INBXInhibrx	$1.79bn	n/a	n/a